Zanubrutinib Market Poised for Explosive Growth, Reaching Over Half a Billion by 2030

The global Zanubrutinib market is capturing significant attention within the pharmaceutical and oncology sectors. As a next-generation Bruton's tyrosine kinase (BTK) inhibitor, zanubrutinib offers a targeted therapeutic approach for various B-cell ma...